Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1)

Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI...

Full description

Saved in:
Bibliographic Details
Published inHeart and vessels Vol. 37; no. 2; pp. 208 - 218
Main Authors Takasaki, Akihiro, Kurita, Tairo, Hirabayashi, Yosuke, Matsuo, Hiroshi, Tanoue, Akiko, Masuda, Jun, Yamanaka, Takashi, Katayama, Kan, Machida, Hirofumi, Ichikawa, Takehiko, Ito, Masaaki, Dohi, Kaoru
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.02.2022
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 ( p  < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm . UMIN000036020 and UMIN000008128
AbstractList Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 (p < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm. UMIN000036020 and UMIN000008128
Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 (p < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm . UMIN000036020 and UMIN000008128.
Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 (p < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm . UMIN000036020 and UMIN000008128.Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 (p < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm . UMIN000036020 and UMIN000008128.
Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional era. We examined 4509 AMI patients (89 AMI/HD and 4420 AMI/non-HD) from the Mie ACS registry and detailed prognostic analyses based on the Killip classification were performed (Cohort A). In addition, prognosis of Killip class1 AMI/HD was compared with those of 313 non-AMI/HD patients from the MIE-CARE HD study using propensity score-matching method (Cohort B). Primary endpoint was all-cause mortality for up to 2 years. All-cause death occurred in 13.0% of AMI/non-HD and 35.8% of AMI/HD during follow-up, and patients with Killip class 1 had lower 30-day and 2-year mortality than those with Killip class ≥ 2 in both AMI/non-HD and AMI/HD. Cox regression analyses identified that Killip class ≥ 2 was the strongest independent prognostic factor of 30-day mortality with a hazard ratio of 7.44 ( p  < 0.001), whereas both presence of HD and Killip class ≥ 2 were the independent prognostic factors of mortality for up to 2 years. In Cohort B, a propensity score-matching analysis revealed similar all-cause mortality rates between Killip class 1 AMI/HD and non-AMI/HD. In HD patients with Killip class 1 AMI, 30-day mortality was around 6%, and long-term mortality among 30-day survivors after AMI was comparable with the natural course of HD patients in the modern interventional era. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/index-j.htm . UMIN000036020 and UMIN000008128
Author Hirabayashi, Yosuke
Yamanaka, Takashi
Ito, Masaaki
Takasaki, Akihiro
Machida, Hirofumi
Matsuo, Hiroshi
Dohi, Kaoru
Masuda, Jun
Ichikawa, Takehiko
Tanoue, Akiko
Kurita, Tairo
Katayama, Kan
Author_xml – sequence: 1
  givenname: Akihiro
  surname: Takasaki
  fullname: Takasaki, Akihiro
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 2
  givenname: Tairo
  orcidid: 0000-0002-2882-6512
  surname: Kurita
  fullname: Kurita, Tairo
  email: k_siho_yuu@hotmail.com
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 3
  givenname: Yosuke
  surname: Hirabayashi
  fullname: Hirabayashi, Yosuke
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 4
  givenname: Hiroshi
  surname: Matsuo
  fullname: Matsuo, Hiroshi
  organization: Department of Nephrology, Suzuka Kaisei Hospital
– sequence: 5
  givenname: Akiko
  surname: Tanoue
  fullname: Tanoue, Akiko
  organization: Department of Nephrology, Murase Hospital
– sequence: 6
  givenname: Jun
  surname: Masuda
  fullname: Masuda, Jun
  organization: Department of Cardiology, Mie Prefectural General Medical Center
– sequence: 7
  givenname: Takashi
  surname: Yamanaka
  fullname: Yamanaka, Takashi
  organization: Department of Cardiology, Yokkaichi Hazu Medical Center
– sequence: 8
  givenname: Kan
  surname: Katayama
  fullname: Katayama, Kan
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 9
  givenname: Hirofumi
  surname: Machida
  fullname: Machida, Hirofumi
  organization: Department of Nephrology, Takeuchi Hospital
– sequence: 10
  givenname: Takehiko
  surname: Ichikawa
  fullname: Ichikawa, Takehiko
  organization: Department of Cardiology, Kuwana City Medical Center
– sequence: 11
  givenname: Masaaki
  surname: Ito
  fullname: Ito, Masaaki
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 12
  givenname: Kaoru
  surname: Dohi
  fullname: Dohi, Kaoru
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34347137$$D View this record in MEDLINE/PubMed
BookMark eNp9kctuFDEQRS0URCaBH2CBLLEJiwY_x91LFPESkWABa8tjlxNH3fZguyPNf_GBuGcyIsoiKz_q3Oty3TN0ElMEhF5T8p4Soj4UQnhPOsJoR-hAh049Qyu6prJjUvETtCIDJV3PmTpFZ6XcEkJlw16gUy64UJSrFfr7M6frmEooOHls7FwBT7tkTXbBjDhEb7KtIcW2xVtTA8Ta0IhvYEoLslukpeZW8gEc3uzw9zCOYYvtaEppl9Yc9fWmmScHeTlVyHfNrJXaO5ANvvDJznvvhds-7OuhI6bvXqLn3owFXt2v5-j350-_Lr92Vz--fLv8eNVZsZa1o2tGjZPCSsUGJ4beWVBe9tRvlHd22KjeGyp6aeUge6escwy4IYJIAOMYP0cXB9_WzJ8ZStVTKBbG0URIc9FMyp4MXFLR0LeP0Ns05_a1Rq0ZF6zFshi-uafmzQROb3OYTN7pYx4N6A-AzamUDF7bUPfzaxMOo6ZEL9HrQ_S6Ra_30etFyh5Jj-5PivhBVBocryH_b_sJ1T8NZcQG
CitedBy_id crossref_primary_10_1016_j_compbiomed_2024_107950
crossref_primary_10_1253_circj_CJ_22_0217
crossref_primary_10_3389_fcvm_2022_803532
Cites_doi 10.1161/CIRCULATIONAHA.109.865352
10.1161/JAHA.115.002460
10.1053/euhj.2001.3081
10.1161/CIRCULATIONAHA.117.029289
10.1016/j.ijcard.2019.01.011
10.1001/archinte.163.19.2345
10.1186/s41100-019-0252-5
10.1007/s00380-018-1122-8
10.1056/NEJMoa0908610
10.1161/CIRCOUTCOMES.119.005879
10.1253/circj.CJ-14-0808
10.1053/ajkd.2000.17676
10.1016/j.jjcc.2017.09.006
10.1253/circj.CJ-20-0112
10.1007/s00380-015-0673-1
10.1016/j.amjcard.2009.05.051
10.1056/NEJM199809173391203
10.1111/j.1744-9987.2012.01144.x
10.1016/j.amjcard.2011.07.062
10.1253/circj.CJ-17-0393
10.1016/j.ahj.2011.12.002
10.1253/circj.CJ-17-1275
10.1016/0002-9149(67)90023-9
ContentType Journal Article
Copyright Springer Japan KK, part of Springer Nature 2021
2021. Springer Japan KK, part of Springer Nature.
Springer Japan KK, part of Springer Nature 2021.
Copyright_xml – notice: Springer Japan KK, part of Springer Nature 2021
– notice: 2021. Springer Japan KK, part of Springer Nature.
– notice: Springer Japan KK, part of Springer Nature 2021.
DBID AAYXX
CITATION
NPM
7QO
8FD
FR3
K9.
P64
7X8
DOI 10.1007/s00380-021-01919-7
DatabaseName CrossRef
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1615-2573
EndPage 218
ExternalDocumentID 34347137
10_1007_s00380_021_01919_7
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
203
28-
29I
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
NPM
7QO
8FD
ABRTQ
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c465t-1621ad54c5729d498dce7f581fb7fdc9b78fa1485c5958d7cdd2e3a0405eead23
IEDL.DBID U2A
ISSN 0910-8327
1615-2573
IngestDate Tue Aug 05 10:02:11 EDT 2025
Sat Aug 16 15:53:30 EDT 2025
Wed Feb 19 02:26:58 EST 2025
Tue Jul 01 00:51:11 EDT 2025
Thu Apr 24 22:54:51 EDT 2025
Fri Feb 21 02:46:26 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Prognosis
Killip class
Hemodialysis
AMI
Language English
License 2021. Springer Japan KK, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-1621ad54c5729d498dce7f581fb7fdc9b78fa1485c5958d7cdd2e3a0405eead23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2882-6512
PMID 34347137
PQID 2623426152
PQPubID 36867
PageCount 11
ParticipantIDs proquest_miscellaneous_2558093514
proquest_journals_2623426152
pubmed_primary_34347137
crossref_citationtrail_10_1007_s00380_021_01919_7
crossref_primary_10_1007_s00380_021_01919_7
springer_journals_10_1007_s00380_021_01919_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-02-01
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Heart and vessels
PublicationTitleAbbrev Heart Vessels
PublicationTitleAlternate Heart Vessels
PublicationYear 2022
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References Szummer, Lindhagen, Evans, Spaak, Koul, Åkerblom, Carrero, Jernberg (CR6) 2019; 12
Shroff, Li, Herzog (CR3) 2015; 4
Fox, Muntner, Chen, Alexander, Roe, Cannon, Saucedo, Kontos, Wiviott (CR14) 2010; 121
Herzog, Ma, Collins (CR15) 1998; 339
Hioki, Motoki, Izawa, Kashima, Miura, Ebisawa, Tomita, Miyashita, Koyama, Ikeda (CR24) 2016; 31
Granger (CR19) 2003; 163
Masuda, Kishi, Kumagai, Yamazaki, Sakata, Higuma, Ogimoto, Dohi, Tanigawa, Hanada, Nakamura, Sokejima, Takayama, Higaki, Yamagishi, Okumura, Ito (CR9) 2018; 82
Shroff, Frederick, Herzog (CR16) 2012; 163
Killip, Kimball (CR18) 1967; 20
Yeh, Sidney, Chandra, Sorel, Selby (CR7) 2010; 362
Fujii, Suzuki, Torii, Murakami, Nakano, Nakazawa, Masuda, Shinozaki, Matsukage, Ogata, Yoshimachi, Ikari (CR21) 2014; 78
Fukuoka, Kurita, Dohi, Masuda, Seko, Tanigawa, Saito, Kakimoto, Makino, Ito (CR8) 2019; 289
Komiyama, Nakamura, Tanabe, Niikura, Fujimoto, Oikawa, Daida, Yamamoto, Nagao, Takayama (CR22) 2018; 71
Yeh, Sidney, Chandra, Sorel, Selby, Go (CR4) 2010; 362
Garcia-Garcia, McFadden, Farb, Mehran, Stone, Spertus, Onuma, Morel, Van Es, Zuckerman, Fearon, Taggart, Kappetein, Krucoff, Vranckx, Windecker, Cutlip, Serruys (CR12) 2018; 137
Movahed, John, Hashemzadeh, Jamal, Hashemzadeh (CR5) 2009; 104
Takasaki, Kurita, Masuda, Hoshino, Seko, Tanigawa, Kitamura, Ichikawa, Ito, Dohi (CR10) 2020; 85
Akashi, Sakakura, Watanabe, Noguchi, Taniguchi, Yamamoto, Wada, Momomura, Fujita (CR17) 2018; 33
Gurm, Gore, Anderson, Wyman, Fox, Steg, Eagle, Registry, Events (CR23) 2012; 109
Nitta, Abe, Masakane, Hanafusa, Taniguchi, Hasegawa, Nakai, Wada, Hamano, Hoshino, Joki, Goto, Wakasugi, Yamamoto, Nakamoto, Maeno, Kawata, Oyama, Seino, Sato, Sato, Ito, Kazama, Ueda, Saito, Ando, Ogawa, Kumagai, Terawaki, Ando, Abe, Kashiwagi, Hamada, Shibagaki, Hirawa, Shimada, Ishida, Yokoyama, Miyazaki, Fukasawa, Kamijyo, Matsuoka, Kato, Mori, Ito, Kasuga, Koyabu, Arimura, Hashimoto, Inaba, Hayashi, Yamakawa, Nishi, Fujimori, Yoneda, Negi, Nakaoka, Ito, Sugiyama, Masaki, Nitta, Okada, Yamanaka, Kan, Ota, Tamura, Mitsuiki, Ikeda, Nishikido, Miyata, Tomo, Fujimoto, Nosaki, Oshiro (CR1) 2020; 6
Fox, Goodman, Klein, Brieger, Steg, Dabbous, Avezum (CR20) 2002; 23
Wakasugi, Kazama, Yamamoto, Kawamura, Narita (CR2) 2013; 17
Matsuo, Dohi, Machida, Takeuchi, Aoki, Nishimura, Yasutomi, Senga, Ichikawa, Kakuta, Mizutani, Tanoue, Isaka, Oosugi, Koyabu, Sakurai, Fukui, Kakimoto, Sugimoto, Ohnishi, Murata, Ishikawa, Okamoto, Yamada, Ogura, Nishimura, Tanigawa, Nomura, Nishikawa, Ito (CR11) 2018; 82
Iseki, Fukiyama (CR13) 2000; 36
CA Herzog (1919_CR15) 1998; 339
CS Fox (1919_CR14) 2010; 121
K Szummer (1919_CR6) 2019; 12
K Nitta (1919_CR1) 2020; 6
M-R Movahed (1919_CR5) 2009; 104
RW Yeh (1919_CR7) 2010; 362
H Matsuo (1919_CR11) 2018; 82
T Killip (1919_CR18) 1967; 20
T Fujii (1919_CR21) 2014; 78
RW Yeh (1919_CR4) 2010; 362
K Iseki (1919_CR13) 2000; 36
S Fukuoka (1919_CR8) 2019; 289
GR Shroff (1919_CR3) 2015; 4
A Takasaki (1919_CR10) 2020; 85
HM Garcia-Garcia (1919_CR12) 2018; 137
KAA Fox (1919_CR20) 2002; 23
GR Shroff (1919_CR16) 2012; 163
M Wakasugi (1919_CR2) 2013; 17
N Akashi (1919_CR17) 2018; 33
CB Granger (1919_CR19) 2003; 163
H Hioki (1919_CR24) 2016; 31
HS Gurm (1919_CR23) 2012; 109
J Masuda (1919_CR9) 2018; 82
K Komiyama (1919_CR22) 2018; 71
References_xml – volume: 121
  start-page: 357
  year: 2010
  end-page: 365
  ident: CR14
  article-title: Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.865352
– volume: 4
  start-page: e002460
  issue: 10
  year: 2015
  ident: CR3
  article-title: Trends in mortality following acute myocardial infarction among dialysis patients in the united states over 15 years
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.115.002460
– volume: 23
  start-page: 1177
  year: 2002
  end-page: 1189
  ident: CR20
  article-title: Management of acute coronary syndromes. Variations in practice and outcome: findings from the Global Registry of Acute Coronary Events (GRACE)
  publication-title: Eur Heart J
  doi: 10.1053/euhj.2001.3081
– volume: 137
  start-page: 2635
  year: 2018
  end-page: 2650
  ident: CR12
  article-title: Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.117.029289
– volume: 289
  start-page: 12
  year: 2019
  end-page: 18
  ident: CR8
  article-title: Untangling the obesity paradox in patients with acute myocardial infarction after primary percutaneous coronary intervention (detail analysis by age)
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.01.011
– volume: 163
  start-page: 2345
  year: 2003
  end-page: 2353
  ident: CR19
  article-title: Predictors of hospital mortality in the global registry of acute coronary events
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.19.2345
– volume: 6
  start-page: 1
  year: 2020
  end-page: 16
  ident: CR1
  article-title: Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes
  publication-title: Ren Replace Ther
  doi: 10.1186/s41100-019-0252-5
– volume: 33
  start-page: 713
  year: 2018
  end-page: 721
  ident: CR17
  article-title: The comparison of clinical outcomes in patients with acute myocardial infarction and advanced chronic kidney disease on chronic hemodialysis versus off hemodialysis
  publication-title: Heart Vessel
  doi: 10.1007/s00380-018-1122-8
– volume: 362
  start-page: 2155
  year: 2010
  end-page: 2165
  ident: CR7
  article-title: Population trends in the incidence and outcomes of acute myocardial infarction
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908610
– volume: 12
  start-page: e005879
  issue: 9
  year: 2019
  ident: CR6
  article-title: Treatments and mortality trends in cases with and without dialysis who have an acute myocardial infarction: an 18-year nationwide experience
  publication-title: Circ Cardiovasc Qual Outcomes
  doi: 10.1161/CIRCOUTCOMES.119.005879
– volume: 78
  start-page: 2950
  year: 2014
  end-page: 2954
  ident: CR21
  article-title: Diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score in ST-elevation myocardial infarction for in-hospital and 360-day mortality in Japanese patients
  publication-title: Circ J
  doi: 10.1253/circj.CJ-14-0808
– volume: 36
  start-page: 820
  year: 2000
  end-page: 825
  ident: CR13
  article-title: Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group
  publication-title: Am J Kidney Dis
  doi: 10.1053/ajkd.2000.17676
– volume: 71
  start-page: 251
  year: 2018
  end-page: 258
  ident: CR22
  article-title: In-hospital mortality analysis of Japanese patients with acute coronary syndrome using the Tokyo CCU Network database: Applicability of the GRACE risk score
  publication-title: J Cardiol
  doi: 10.1016/j.jjcc.2017.09.006
– volume: 85
  start-page: 9
  year: 2020
  end-page: 18
  ident: CR10
  article-title: Prevalence and prognosis of familial hypercholesterolemia in patients with acute coronary syndrome in Mie prefecture, Japan—report from Mie ACS registry
  publication-title: Circ J
  doi: 10.1253/circj.CJ-20-0112
– volume: 31
  start-page: 687
  year: 2016
  end-page: 693
  ident: CR24
  article-title: Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction
  publication-title: Heart Vessel
  doi: 10.1007/s00380-015-0673-1
– volume: 104
  start-page: 1030
  year: 2009
  end-page: 1034
  ident: CR5
  article-title: Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988–2004) based on race, gender, infarct location and comorbidities
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2009.05.051
– volume: 362
  start-page: 2155
  year: 2010
  end-page: 2165
  ident: CR4
  article-title: Population trends in the incidence and outcomes of acute myocardial infarction
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908610
– volume: 339
  start-page: 799
  year: 1998
  end-page: 805
  ident: CR15
  article-title: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199809173391203
– volume: 17
  start-page: 298
  year: 2013
  end-page: 304
  ident: CR2
  article-title: Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1744-9987.2012.01144.x
– volume: 109
  start-page: 19
  year: 2012
  end-page: 25
  ident: CR23
  article-title: Investigators G. Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] registry )
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2011.07.062
– volume: 82
  start-page: 586
  year: 2018
  end-page: 595
  ident: CR11
  article-title: Echocardiographic assessment of cardiac structural and functional abnormalities in patients with end-stage renal disease receiving chronic hemodialysis
  publication-title: Circ J
  doi: 10.1253/circj.CJ-17-0393
– volume: 163
  start-page: 399
  year: 2012
  end-page: 406
  ident: CR16
  article-title: Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes o
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2011.12.002
– volume: 82
  start-page: 1666
  year: 2018
  end-page: 1674
  ident: CR9
  article-title: Rural-urban disparity in emergency care for acute myocardial infarction in Japan
  publication-title: Circ J
  doi: 10.1253/circj.CJ-17-1275
– volume: 20
  start-page: 457
  year: 1967
  end-page: 464
  ident: CR18
  article-title: Treatment of myocardial infarction in a coronary care unit
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(67)90023-9
– volume: 104
  start-page: 1030
  year: 2009
  ident: 1919_CR5
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2009.05.051
– volume: 339
  start-page: 799
  year: 1998
  ident: 1919_CR15
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199809173391203
– volume: 78
  start-page: 2950
  year: 2014
  ident: 1919_CR21
  publication-title: Circ J
  doi: 10.1253/circj.CJ-14-0808
– volume: 82
  start-page: 586
  year: 2018
  ident: 1919_CR11
  publication-title: Circ J
  doi: 10.1253/circj.CJ-17-0393
– volume: 137
  start-page: 2635
  year: 2018
  ident: 1919_CR12
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.117.029289
– volume: 163
  start-page: 2345
  year: 2003
  ident: 1919_CR19
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.19.2345
– volume: 12
  start-page: e005879
  issue: 9
  year: 2019
  ident: 1919_CR6
  publication-title: Circ Cardiovasc Qual Outcomes
  doi: 10.1161/CIRCOUTCOMES.119.005879
– volume: 109
  start-page: 19
  year: 2012
  ident: 1919_CR23
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2011.07.062
– volume: 4
  start-page: e002460
  issue: 10
  year: 2015
  ident: 1919_CR3
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.115.002460
– volume: 71
  start-page: 251
  year: 2018
  ident: 1919_CR22
  publication-title: J Cardiol
  doi: 10.1016/j.jjcc.2017.09.006
– volume: 362
  start-page: 2155
  year: 2010
  ident: 1919_CR7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908610
– volume: 36
  start-page: 820
  year: 2000
  ident: 1919_CR13
  publication-title: Am J Kidney Dis
  doi: 10.1053/ajkd.2000.17676
– volume: 23
  start-page: 1177
  year: 2002
  ident: 1919_CR20
  publication-title: Eur Heart J
  doi: 10.1053/euhj.2001.3081
– volume: 163
  start-page: 399
  year: 2012
  ident: 1919_CR16
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2011.12.002
– volume: 85
  start-page: 9
  year: 2020
  ident: 1919_CR10
  publication-title: Circ J
  doi: 10.1253/circj.CJ-20-0112
– volume: 20
  start-page: 457
  year: 1967
  ident: 1919_CR18
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(67)90023-9
– volume: 289
  start-page: 12
  year: 2019
  ident: 1919_CR8
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.01.011
– volume: 17
  start-page: 298
  year: 2013
  ident: 1919_CR2
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1744-9987.2012.01144.x
– volume: 31
  start-page: 687
  year: 2016
  ident: 1919_CR24
  publication-title: Heart Vessel
  doi: 10.1007/s00380-015-0673-1
– volume: 362
  start-page: 2155
  year: 2010
  ident: 1919_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908610
– volume: 82
  start-page: 1666
  year: 2018
  ident: 1919_CR9
  publication-title: Circ J
  doi: 10.1253/circj.CJ-17-1275
– volume: 121
  start-page: 357
  year: 2010
  ident: 1919_CR14
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.865352
– volume: 33
  start-page: 713
  year: 2018
  ident: 1919_CR17
  publication-title: Heart Vessel
  doi: 10.1007/s00380-018-1122-8
– volume: 6
  start-page: 1
  year: 2020
  ident: 1919_CR1
  publication-title: Ren Replace Ther
  doi: 10.1186/s41100-019-0252-5
SSID ssj0015919
Score 2.3010397
Snippet Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 208
SubjectTerms Biomedical Engineering and Bioengineering
Cardiac Surgery
Cardiology
Classification
Heart attacks
Hemodialysis
Matching
Medical prognosis
Medicine
Medicine & Public Health
Mortality
Myocardial infarction
Original Article
Patients
Prognosis
Regression analysis
UMIN
UMIN000008128
UMIN000036020
Vascular Surgery
Title Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1)
URI https://link.springer.com/article/10.1007/s00380-021-01919-7
https://www.ncbi.nlm.nih.gov/pubmed/34347137
https://www.proquest.com/docview/2623426152
https://www.proquest.com/docview/2558093514
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxUxEA7agvhSauvltLWMIKJooMluNruPp9JjsbT44IH6tGRzwULPbjmXh_O__IHOZC8eqQo-7cJOZgMzyXyTuYSx1z71uVMicETHCU9NlfAiFIYLkWXS-WDzQEcDl1fZ-TT9fK2uu6KwRZ_t3ock4049FLtREOuEU0oBwhJRcP2QbSvy3VGLp3I8xA5UIdoOe7jDoL7qrlTmzzx-N0f3MOa9-Gg0O5NdttPhRRi3An7CHvh6j-2Pa_SVZ2t4AzGDMx6N77FHl12gfJ_9-DJvKIXuZgFNAGNXSw-zNdot0odbQLVCBSeZ4Ct0vVWRtIbvftYQCTUqgbanbkCUCtUaLmLcACzhbUowMv14xJAwi3eqwc1GCiX-x88NvA2NXUXeRHe3Oa9NjiDePWXTydnXj-e8u6CB2zRTSy4yKYxTqVUI0V1a5M56HVQuQqWDs0Wl82DQ31JWFSp32jonfWJw31AeNVgmz9hW3dT-BQN0VE-kTbRWiEcRJJlceeesMsFpjxxGTPRyKm3XvZwu0bgth77LUbYlyraMsi31iL0fxty1vTv-SX3Ui7_s1vGilIgOyclUcsReDZ9xBVJYxdS-WSGNUjmFk0U6Ys9btRl-l6QJWv8EmX_o9egX87_P5eD_yA_ZY0lVGTGZ_IhtLecr_xKx0rI6ZtvjyenpFT0_fbs4O45L5Sd_fg9D
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB-0gvoi2vpxWnUEEcUGmt3NJvt4iOW0veJDD_q2ZPOBhd5uuY-H-7_6B3aS_fCkKvi2sJNJYCaZ32Q-AvDeZU5ZwT0jdJyyTFcpK3yhGed5nljnjfLhamB6mk9m2fdzcd4VhS37bPc-JBlP6qHYLQSxDllIKSBYwgsm78I9AgMqJHLNkvEQOxAFbzvs0QlD-iq7Upk_8_jdHN3CmLfio9HsHD2GRx1exHEr4Cdwx9W7sDeuyVeeb_ADxgzOeDW-C_enXaB8D65_LJqQQnexxMajNuuVw_mG7FbQh0sktSIFDzKhT-x6qxJpjT_dvAkkoVEJtj11PaFUrDZ4HOMGaALeDglGuh9PGBLn8U01vNhKoaR53ELjR9-YdeQd6K6217XNEfmnpzA7-nr2ZcK6BxqYyXKxYjxPuLYiM4Igus0KZY2TXijuK-mtKSqpvCZ_SxhRCGWlsTZxqaZzQzjS4CR9Bjt1U7sXgOSoHiYmlVIQHiWQpJVw1hqhvZWOOIyA93IqTde9PDyicVkOfZejbEuSbRllW8oRfB7GXLW9O_5Jvd-Lv-z28bJMCB0GJ1MkI3g3_KYdGMIqunbNmmiEUCGczLMRPG_VZpguzVKy_ikxP-j16Bfzv6_l5f-Rv4UHk7PpSXny7fT4FTxMQoVGTCzfh53VYu1eE25aVW_iNrkBc2YPJg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkSouqA8eS0sZJIRAYLVO4jg5rgqrQmnVAyv1Fjl-qJW6yWqbPez_4gcydh5dVEDiFinjsaUZ2589M58B3trEZkZwxwgdxyxRZcxylyvGeZpGxjqdOX81cHaenkyTb5ficq2KP2S79yHJtqbBszRVzeHcuMOh8M0HtI6YTy8giMJzJh_CI1qOuffraTQe4ggi5y3bHq025LuyK5v5s47ft6Z7ePNerDRsQZMteNJhRxy3xt6GB7bagd1xRefm2QrfYcjmDNfkO7B51gXNd-HnxaL26XTXt1g7VHrZWJytaA_zvnGD5GLk7N4-9IkdzyqJVnhlZ7UX8aQl2PLrOkKsWK7wNMQQUHvs7ZONVN-e8CTOwvtqeL2WTkn92IXC967Wy6Dby83Xx7WuEfmHpzCdfPlxfMK6xxqYTlLRMJ5GXBmRaEFw3SR5ZrSVTmTcldIZnZcyc4rOXkKLXGRGamMiGytaQ4Qlb47iZ7BR1ZV9AUiH1qNIx1IKwqYEmFQmrDFaKGekJQ0j4L2dCt0xmfsHNW6KgYM52LYg2xbBtoUcwcehzbzl8fin9H5v_qKb07dFREjRHzhFNII3w2-ajT7EoipbL0lGiMyHlnkyguet2wzdxUlMSCAm5Z96P7pT_vexvPw_8dewefF5Unz_en66B48jX6wRcsz3YaNZLO0rglBNeRBmyS-_IBNi
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognosis+of+acute+myocardial+infarction+in+patients+on+hemodialysis+stratified+by+Killip+classification+in+the+modern+interventional+era+%28focus+on+the+prognosis+of+Killip+class+1%29&rft.jtitle=Heart+and+vessels&rft.au=Takasaki%2C+Akihiro&rft.au=Kurita%2C+Tairo&rft.au=Hirabayashi%2C+Yosuke&rft.au=Matsuo%2C+Hiroshi&rft.date=2022-02-01&rft.eissn=1615-2573&rft.volume=37&rft.issue=2&rft.spage=208&rft_id=info:doi/10.1007%2Fs00380-021-01919-7&rft_id=info%3Apmid%2F34347137&rft.externalDocID=34347137
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0910-8327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0910-8327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0910-8327&client=summon